EasyMed Re-Files Financial Statements and MD&A

Easymed Technologies Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) (the "Company" or
"EasyMed ") announces that it has amended and re-filed its management discussion
and analysis (the "MD&A") for the year ended October 31, 2012 and interim period
ended April 30, 2013, and condensed consolidated interim financial statements
for the nine months ended July 31, 2013 in response to comments from the BCSC.
The amendments are mainly related to increase the amount of information provided
and to clarify inconsistences in these documents. Significant amendments to the
MD&A are as follows: 




----------------------------------------------------------------------------
                                                     Six months             
                                                          ended   Year ended
                                                      April 30,  October 30,
                                                           2013         2012
----------------------------------------------------------------------------
A table has been added to the section "Forward                              
 Looking Statements" to disclose the material                               
 assumptions used to develop significant forward-                           
 looking statements and material risk factors that                          
 could cause actual results to differ materially                            
 from the forward looking statements.                         X            X
----------------------------------------------------------------------------
Sections of "Overall Market Trend", "Company's                              
 Products", "Research and Development Cost" and                             
 "Outlook" have been added to the Amended 2012 MD&A                         
 to enable readers to understand the Company's                              
 outlook, corporate development, and product                                
 development with more details.                               X            X
----------------------------------------------------------------------------
"Selected Quarterly Information" - more disclosure                          
 has been added to explain the significant quarter                          
 to quarter movements within the past eight recent                          
 quarters.                                                    X            X
----------------------------------------------------------------------------
Result of the Year Ended October 31, 2012 - A                               
 breakdown of the Company's operating expenses by                           
 nature in fiscal 2012 and 2011 has been added with                         
 analysis of the year to year movement have been                            
 added                                                      N/A            X
----------------------------------------------------------------------------
"Three Months Ended October 31, 2012" - A breakdown                         
 of the Company's operating expenses by nature in                           
 the fourth quarter of 2012 and 2011 has been added                         
 with analysis of the year to year movement have                            
 been added                                                 N/A            X
----------------------------------------------------------------------------
"Result of the Six months ended April 30, 2013                              
 period" - A breakdown of the Company's operating                           
 expenses by nature in the six months ended April                           
 30, 2013 with analysis of movement has been added            X          N/A
----------------------------------------------------------------------------
A section of "Three months ended April 30, 2013"                            
 has been added to provide more details of the                              
 Company's operating activities happened during the                         
 three months ended April 30, 2013.                           X          N/A
----------------------------------------------------------------------------
"Related Party Transaction" - a breakdown of the                            
 fees charged by key management have been added.              X            X
----------------------------------------------------------------------------
Information relating to the Company's share                                 
 capital, warrant, options have been updated to                             
 October 1, 2013, the date of the Amended MD&A                X            X
----------------------------------------------------------------------------
The Company changed its name to Easymed                                     
 Technologies Inc. and its registered office                                
 address commencing October 18, 2013                          X            X
----------------------------------------------------------------------------
The Company consolidated its issued and outstanding                         
 shares on a 5-1 basis on October 18, 2013. The                             
 presentation of number of outstanding shares,                              
 warrants, options, and loss per share have been                            
 updated to reflect this 5-1 share consolidation              X            X
----------------------------------------------------------------------------



Significant amendments to the consolidated interim financial statements for the
nine months ended July 31, 2013 are as follows:




--  An explicit and unreserved statement of compliance with IAS 34 has been
    added to the statement of compliance in Note 2 (Basis of Presentation) 
--  Factors that indicate the existence of a material uncertainty that cast
    significant doubt about the Company's ability to continue as a going
    concern have been added to Note 2 (Basis of Presentation) 
--  Outstanding balance of various related party loan as at October 31,
    2012, and the amount of accrued interest in connection with related
    party loan as at October 31, 2012 and July 31, 2013 have been added to
    the Note 5 (Related Party Transaction) 
--  A breakdown of remuneration paid to key management during the reporting
    periods have been added to Note 5 (Related Party Transaction) 
--  Disclosure about the assumptions used in Black-Scholes Option Pricing
    Model in order to establish stock based compensation incurred during
    nine months ended July 31, 2013 have been added in Note 4 (Share
    Capital) 
--  Disclosure of the CHF equivalent of various loan denominated in foreign
    currencies have been added to the Note 9 (Commitment) 
--  Note 11 (Subsequent events) has been added to disclose the Company's
    name change, change of office, and 5-1 share consolidation commenced on
    October 18, 2013. 



ON BEHALF OF THE BOARD 

Jared Scharf, CFO & Director

About Easymed Technologies Inc.

Easymed Technologies Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) is a global medical
information technology company delivering a end to end patient care solution
through mobile phone/PDA and server technologies offering specialized services
and applications for healthcare, insurance and pharmaceutical industries. We are
committed to world class customer service and the protection of our clients'
information. For more information, visit www.easymedmobile.com. 


This news release contains forward-looking statements, which relate to future
events or future performance and reflect management's current expectations and
assumptions. These forward-looking statements reflect management's current
beliefs and are based on assumptions made by and information currently available
to the Company. Investors are cautioned that these forward looking statements
are neither promises nor guarantees, and are subject to risks and uncertainties
that may cause future results to differ materially from those expected. These
forward-looking statements are made as of the date hereof and, except as
required under applicable securities legislation, the Company does not assume
any obligation to update or revise them to reflect new events or circumstances. 


These securities have not and will not be registered under the United States
Securities Act of 1933 or any state securities laws and may not be offered or
sold in the United States or to a U.S. Person unless so registered, or an
exemption from registration is available to be relied upon. This news release
does not constitute an offer of securities for sale in the United States.


The CNSX has not reviewed and does not accept responsibility for the adequacy or
accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Easymed Technologies Inc.
Jared W. Scharf
CFO & Director
[phone]
www.easymedmobile.com